Search Within

Mackenzie Myers

Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (15)
  2. Department of Medicine (15)
  3. GSK Faculty (15)
  4. Solid Tumor Oncology Division (15)
  5. Thoracic Oncology (15)
  6. Weinberg Fellows (15)

More Groups

People
  1. Bob Li (15)
  2. Charles Rudin (14)
  3. Michael Offin (14)
  4. Maria Arcila (12)
  5. David Jones (8)
  6. James Isbell (8)

More People

Years
  1. 2020 (3)
  2. 2019 (8)
  3. 2018 (4)
Publications
  1. Journal of Clinical Oncology (5)
  2. Journal of Thoracic Oncology (3)
  3. Acta Oncologica (1)
  4. Cancer (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. Informa Healthcare (1)
  5. Oxford University Press (1)
  6. Society of Nuclear Medicine (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Hui, A. B.; Chabon, J. J.; Moding, E. J.; Lebow, E. S.; Araujo, J. A.; Isbell, J. M.; Jones, D. R.; Ginsberg, M. S.; Myers, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Lebow, E. S.; Tu, H. Y.; Li, M.; Lim, L. P.; Arbour, K. C.; Travis, W.; Solit, D. B.; Ladanyi, M.; Jones, D. R.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
    Journal Article

    Mondaca, S.; Offin, M.; Borsu, L.; Myers, M.; Josyula, S.; Makhnin, A.; Shen, R.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; more...
    Acta Oncologica (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor volumetric correlation with plasma cell free DNA (cfDNA) mutation detection in metastatic lung cancers
    Meeting Abstract

    Haseltine, J.; Offin, M.; Myers, M. L.; Makhnin, A.; Adamski, A.; Li, H.; Li, M.; Shaffer, T.; Henderson, S.; Shen, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • 89Zr-trastuzumab PET/CT for prediction of response to HER2-targeted therapy in patients with HER2 mutant lung cancer: An exploratory phase 2 trial
    Meeting Abstract

    Ulaner, G.; Offin, M.; Scaltriti, M.; Myers, M.; Venkatesh, A.; Panora, E.; Kris, M.; Rudin, C.; Arcila, M.; Lyashchenko, S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save